Type I and Type II psoriasis Show a Similar Usage of T-Cell Receptor Variable Regions
- 1 December 1991
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 97 (6) , 1053-1056
- https://doi.org/10.1111/1523-1747.ep12492569
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cyclosporine A in the Treatment of Psoriasis: A Clinical and Mechanistic PerspectiveJournal of Investigative Dermatology, 1990
- Autoimmune Diseases: The Failure of Self ToleranceScience, 1990
- Protection from experimental allergic encephalomyelitis conferred by a monoclonal antibody directed against a shared idiotype on rat T cell receptors specific for myelin basic protein.The Journal of Experimental Medicine, 1988
- Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapyCell, 1988
- Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune interventionCell, 1988
- Monoclonal Antibodies Cross-Reactive with Group A Streptococci and Normal and Psoriatic Human SkinJournal of Investigative Dermatology, 1986
- Psoriasis of early and late onset: Characterization of two types of psoriasis vulgarisJournal of the American Academy of Dermatology, 1985
- A VIRUS‐LIKE PARTICLE ASSOCIATED WITH PSORIASISActa Pathologica Microbiologica Scandinavica Series B: Microbiology, 1983
- Reappearance of epidermal Langerhans cells after PUVA therapyBritish Journal of Dermatology, 1983
- Expression of HLA-DR Antigen in Skin from Patients with PsoriasisJournal of Investigative Dermatology, 1982